Naveed Z. Janjua, Dr.P.H.
Affiliations: | 2007 | University of Alabama, Birmingham, Birmingham, AL, United States |
Area:
Epidemiology, Public Health, ToxicologyGoogle:
"Naveed Janjua"Cross-listing: PHTree
Parents
Sign in to add mentor| Nalini Sathiakumar | grad student | 2007 | UAB | |
| (Prenatal lead exposure in Karachi: Magnitude, determinants and effect on birth weight.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Butt ZA, Wong S, Rossi C, et al. (2020) Concurrent Hepatitis C and B Virus and Human Immunodeficiency Virus Infections Are Associated With Higher Mortality Risk Illustrating the Impact of Syndemics on Health Outcomes. Open Forum Infectious Diseases. 7: ofaa347 |
| Valerio H, Alavi M, Law M, et al. (2020) High hepatitis C treatment uptake among people with recent drug dependence in New South Wales, Australia. Journal of Hepatology |
| Young J, Wong S, Janjua NZ, et al. (2020) Comparing direct acting antivirals for hepatitis C using observational data - Why and how? Pharmacology Research & Perspectives. 8: e00650 |
| Hamadeh A, Haines A, Feng Z, et al. (2020) Estimating chronic hepatitis C prevalence in British Columbia and Ontario, Canada using population-based cohort studies. Journal of Viral Hepatitis |
| Clementi E, Bartlett S, Otterstatter M, et al. (2020) Syndemic profiles of people living with hepatitis C virus using population-level latent class analysis to optimize health services. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases |
| Janjua NZ, Wong S, Darvishian M, et al. (2020) The impact of SVR from direct acting antiviral and interferon- based treatments for HCV on hepatocellular carcinoma risk. Journal of Viral Hepatitis |
| Wilton J, Wong S, Yu A, et al. (2020) Real-world Effectiveness of Sofosbuvir/Velpatasvir for Treatment of Chronic Hepatitis C in British Columbia, Canada: A Population-Based Cohort Study. Open Forum Infectious Diseases. 7: ofaa055 |
| Min JE, Pearce LA, Janjua N, et al. (2020) The causal effect of opioid agonist treatment on adherence to direct-acting antiviral treatment for Hepatitis C Virus Open Forum Infectious Diseases |
| Hajarizadeh B, Cunningham EB, Valerio H, et al. (2019) Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis. Journal of Hepatology |
| Darvishian M, Wong S, Binka M, et al. (2019) Loss to follow-up: a significant barrier in the treatment cascade with direct-acting therapies. Journal of Viral Hepatitis |